Financial Daily from THE HINDU group of publications
Thursday, Jul 04, 2002

News
Features
Stocks
Port Info
Archives

Group Sites

Corporate - Research & Development


German pharma co plans research in India on AIDS

Our Bureau

CHENNAI, July 3

THE German pharmaceutical company, von Hoffmeister Pharma GmbH, is planning to set up a joint venture company in India to carry out research in the use of medicines derived from cannabis in AIDS therapy.

Speaking to newspersons, Mr Karthikeyan Ramanathan, R&D Management Analyst at von Hoffmeister, said that the use of cannabis is an integral part of ayurvedic medications. India has vast untapped sources of herbal medications, and most important in areas of cannabinoid pharmacology.

According to him, although it is very well documented in literature that cannabis has been historically used for its medical value, the Marijuana Tax Act passed in the US in 1937, banned the use of the plant parts for any medication or industry. This killed the scope for research in the use of cannabis in medicine.

Send this article to Friends by E-Mail

Stories in this Section
German pharma co plans research in India on AIDS


Ranbaxy gets US FDA nod for Lisinopril
Hepatitis B vaccine prices slashed
SEBI panel findings on buyback by month-end
ICAI renames auditing practices panel — Regulatory bodies, public to have a say henceforth
Jargons ajar
HDFC subscribes to 6.9 pc preference shares of RIL
Sasken converts Japanese arm into branch office
Sesa Goa seeks to dispose of Sirsaim unit
ACC to sell stake in Intl Ferrites in Rs 40-cr deal
Idea Cellular-BPL merger in a limbo
IOC denies imposing fresh riders on HPL
Alfa Laval India to be hub for global projects business
Singareni Collieries hopes to wipe out losses this fiscal
Sanofi-Synthelabo eyes 20% growth in topline
M.K. Sinha takes over at NCL
Alstom board reconstituted


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | Home |

Copyright © 2002, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line